New therapeutic approaches to arterial calcification via inhibition of transglutaminase and β-catenin signaling

Current Pharmaceutical Design

Volumn 20, Issue 37, 2014, Pages 5811-5820

  Konoplyannikov, Mikhail ^a   Nurminskaya, Maria ^b  

^a FEDERAL BIOMEDICAL AGENCY OF RUSSIA   (Russian Federation)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Arterial calcification; Quercetin; Transglutaminase 2; Warfarin; catenin

Indexed keywords

BETA CATENIN; BONE MORPHOGENETIC PROTEIN; ENZYME INHIBITOR; FETUIN A; KCC 009; LIPID; MATRIX GLA PROTEIN; MICRORNA; OSTEOPONTIN; PEPTIDES AND PROTEINS; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; QUERCETIN; UNCLASSIFIED DRUG; WARFARIN; ISOXAZOLE DERIVATIVE;

APOPTOSIS; ARTERY CALCIFICATION; ARTICLE; CARDIOVASCULAR DISEASE; CARTILAGE CELL; CELL DEATH; ENDOTHELIUM CELL; ENZYME INHIBITION; HEMATOPOIETIC STEM CELL; HUMAN; NONHUMAN; PERICYTE; VASCULAR SMOOTH MUSCLE; VASCULAR SMOOTH MUSCLE CELL; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; ENZYMOLOGY; METABOLISM; SIGNAL TRANSDUCTION; VASCULAR CALCIFICATION;

ANIMALS; BETA CATENIN; ENZYME INHIBITORS; HUMANS; ISOXAZOLES; SIGNAL TRANSDUCTION; TRANSGLUTAMINASES; VASCULAR CALCIFICATION;

EID: 84911465816     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612820666140212205059     Document Type: Article

References (169)

1. Sangiorgi G, Rumberger JA, Severson A, et al. Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans: a histologic study of 723 coronary artery segments using nondecalcifying methodology. J Am Coll Cardiol 1998; 31: 126-33.
2. Allison MA, Criqui MH, Wright CM. Patterns and risk factors for systemic calcified atherosclerosis. Arterioscler Thromb Vasc Biol 2004; 24: 331-6.
3. Moe SM, Chen NX. Pathophysiology of vascular calcification in chronic kidney disease. Circ Res 2004; 95: 560-7.
4. Fuchs U, Caffier P, Schulz HG, Wieniecki P. Arterial calcification in diabetics. Virchows Arch A Pathol Anat Histopathol 1985; 407: 431-9.
5. Reaven PD, Sacks J. Coronary artery and abdominal aortic calcification are associated with cardiovascular disease in type 2 diabetes. Diabetologia 2005; 48: 379-85.
6. Leopold JA. Vascular calcification: an age-old problem of old age. Circulation 2013; 127(24): 2380-2.
7. Mönckeberg JG. Über die reine Mediaverkalkung der Extremitätenarterien und ihr Verhalten zur Arteriosklerose. Virchows Arch Pathol Anat Physiol Klin Med 1903; 171: 141-67.
8. Rennenberg RJ, Kessels AG, Schurgers LJ, van Engelshoven JM, de Leeuw PW, Kroon AA. Vascular calcifications as a marker of increased cardiovascular risk: a meta-analysis. Vasc Health Risk Manag 2009; 5(1): 185-97.
9. Shanahan CM, Cary NR, Salisbury JR, Proudfoot D, Weissberg PL, Edmonds ME. Mediallocalization of mineralization-regulating proteins in association with Mönckeberg sclerosis: evidence for smooth muscle cell-mediated vascular calcification. Circulation 1999; 100: 2168-76.
10. Vattikuti R, Towler DA. Osteogenic regulation of vascular calcification: an early perspective. Am J Physiol Endocrinol Metab 2004; 286: E686-96.
11. Hruska KA, Mathew S, Saab G. Bone morphogenetic proteins in vascular calcification. Circ Res 2005; 97: 105-114.
12. Demer LL, Tintut Y. Vascular calcification: pathobiology of a multifaceted disease. Circulation 2008; 117: 2938-48.
13. Boström KI, Rajamannan NM, Towler DA. The regulation of valvular and vascular sclerosis by osteogenic morphogens. Circ Res 2011; 109(5): 564-77.
14. Shanahan CM, Crouthamel MH, Kapustin A, Giachelli CM. Arterial calcification in chronic kidney disease: key roles for calcium and phosphate. Circ Res 2011; 109(6): 697-711.
15. Rutsch F, Nitschke Y, Terkeltaub R. Genetics in arterial calcification: pieces of a puzzle and cogs in a wheel. Circ Res 2011; 109(5): 578-92.
16. Owens DS, Katz R, Johnson E, et al. Interaction of age with lipoproteins as predictors of aortic valve calcification in the multiethnic study of atherosclerosis. Arch Intern Med 2008; 168(11): 1200-7.
17. Canfield AE, Doherty MJ, Wood AC, et al. Role of pericytes in vascular calcification: a review. Z Kardiol 2000; 89 Suppl 2: 20-7.
18. Naik V, Leaf EM, Hu JH, et al. Sources of cells that contribute to atherosclerotic intimal calcification: an in vivo genetic fate mapping study. Cardiovasc Res 2012; 94(3): 545-54.
19. Tintut Y, Abedin M, Cho J, Choe A, Lim J, Demer LL. Regulation of RANKL-induced osteoclastic differentiation by vascular cells. J Mol Cell Cardiol 2005; 39(2): 389-93.
20. Yang S, Eto H, Kato H, et al. Comparative Characterization of Stromal Vascular Cells Derived from Three Types of Vascular Wall and Adipose Tissue. Tissue Eng Part A. 2013 Aug 31. [Epub ahead of print].
21. Cianciolo G, La Manna G, Della Bella E, et al. Effect of vitamin D receptor activator therapy on vitamin D receptor and osteocalcin expression in circulating endothelial progenitor cells of hemodialysis patients. Blood Purif 2013; 35(1-3): 187-95.
22. Cheng SL, Shao JS, Behrmann A, Krchma K, Towler DA. Dkk1 and MSX2-Wnt7b signaling reciprocally regulate the endothelial-mesenchymal transition in aortic endothelial cells. Arterioscler Thromb Vasc Biol 2013; 33(7): 1679-89.
23. Neven E, Persy V, Dauwe S, De Schutter T, De Broe ME, D'Haese PC. Chondrocyte rather than osteoblast conversion of vascular cells underlies medial calcification in uremic rats. Arterioscler Thromb Vasc Biol 2010; 30(9): 1741-50.
24. Speer MY, Yang HY, Brabb T, et al. Smooth muscle cells give rise to osteochondrogenic precursors and chondrocytes in calcifying arteries. Circ. Res 2009; 104: 733-41.
25. Medici D, Shore EM, Lounev VY, Kaplan FS, Kalluri R, Olsen BR. Conversion of vascular endothelial cells into multipotent stemlike cells. Nat Med 2010; 16 (12): 1400-6.
26. Egan CG, Caporali F, Capecchi PL, Lazzerini PE, Pasini FL, Sorrentino V. Levels of circulating CXCR4-positive cells are decreased and negatively correlated with risk factors in cardiac transplant recipients. Heart Vessels 2011; 26(3): 258-66.
27. Bastos Gonçalves F, Voûte MT, Hoeks SE, et al. Calcification of the abdominal aorta as an independent predictor of cardiovascular events: a meta-analysis. Heart 2012; 98(13): 988-94.
28. Yao Y, Jumabay M, Ly A, Radparvar M, Cubberly MR, Boström KI. A role for the endothelium in vascular calcification. Circ Res 2013; 113(5): 495-504.
29. Russo DP, lmiero G, DeBlasio AP, Balletta MM, Andreucci VE. Coronary artery calcification in patients with CRF not undergoing dialysis. Am J Kidney Dis 2004; 44: 1024-30.
30. Kramer H, Toto R, Peshock R, Cooper R, Victor R. Association between chronic kidney disease and coronary artery calcification: the Dallas Heart Study. J Am Soc Nephrol 2005; 16: 507-13.
31. Ossareh S. Vascular calcification in chronic kidney disease: mechanisms and clinical implications. Iran J Kidney Dis 2011; 5: 285-99.
32. Shroff R. Dysregulated mineral metabolism in children with chronic kidney disease. Curr Opin Nephrol Hypertens 2011; 20: 233-40.
33. Dao HH, Essalihi R, Bouvet C, Moreau P. Evolution and modulation of age-related medial elastocalcinosis: impact on large artery stiffness and isolated systolic hypertension. Cardiovasc Res 2005; 66: 307-17.
34. Speer MY, Giachelli CM. Regulation of cardiovascular calcification. Cardiovasc. Pathol 2004; 13: 63-70.
35. Coates T, Kirkland GS, Dymock RB, et al. Cutaneous necrosis from calcific uremic arteriolopathy. Am J Kidney Dis 1998; 32: 384-91.
36. Niskanen L, Siitonen O, Suhonen M, Uusitupa MI. Medial artery calcification predicts cardiovascular mortality in patients with NIDDM. Diabetes Care 1994; 17(11): 1252-6.
37. Rumberger JA, Simons DB, Fitzpatrick LA, Sheedy PF, Schwartz RS. Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study. Circulation 1995; 92: 2157-62.
38. Fitzgerald PJ, Ports TA, Yock PG. Contribution of localized calcium deposits to dissection after angioplasty. An observational study using intravascular ultrasound. Circulation 1992; 86: 64-70.
39. Burke AP, Taylor A, Farb A, Malcom GT, Virmani R. Coronary calcification: insights from sudden coronary death victims. Z. Kardiol 2000; 89: 49-53.
40. Wong KK, Thavornpattanapong P, Cheung SC, Sun Z, Tu J. Effect of calcification on the mechanical stability of plaque based on a three-dimensional carotid bifurcation model. BMC Cardiovasc Disord 2012; 12: 7.
41. Beadenkopf WG, Daoud AS, Love BM. Calcification in the coronary arteries and its relationship to arteriosclerosis and myocardial infarction. Am J Roentgenol Radium Ther Nucl Med 1964; 92: 865-71.
42. Loecker TH, Schwartz RS, Cotta CW, Hickman JR. Fluoroscopic coronary artery calcification and associated coronary disease in asymptomatic young men. J Am Coll Cardiol 1992; 19: 1167-72.
43. Greenland P, Bonow RO, Brundage BH, Budoff MJ, Eisenberg M. J ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force. Circulation 2007; 115: 402-26.
44. O'Keefe JH, Lavie CJ, Nishimura RA, Edwards WD. Degenerative aortic stenosis. One effect of the graying of America. Postgrad Med 1991; 89: 143-6.
45. Lindroos M, Kupari M, Heikkilä J, Tilvis R. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol 1993; 21: 1220-5.
46. Ribeiro S, Ramos A, Brandao A, et al. Cardiac valve calcification in haemodialysis patients: role of calcium-phosphate metabolism. Nephrol Dial Transplant 1998; 13: 2037-40.
47. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet 2006; 368: 1005-1011.
48. Jacobson A. Is there a role for warfarin anymore? Hematology Am Soc Hematol Educ Program 2012; 2012: 541-6.
49. Kidd LR, Hanumantharaya DH. Sprouting a warfarin interaction. BMJ 2010; 341: c2621.
50. Danziger J. Vitamin K-dependent proteins, warfarin, and vascular calcification. Clin J Am Soc Nephrol 2008; 3(5): 1504-10.
51. Lerner RG, Aronow WS, Sekhri A, et al. J Warfarin use and the risk of valvular calcification. Thromb Haemost 2009; 7(12): 2023-7.
52. Rennenberg RJ, Schurgers LJ, Kroon AA, Stehouwer CD. Arterial calcifications. J Cell Mol Med 2010; 14(9): 2203-10.
53. Chatrou ML, Winckers K, Hackeng TM, Reutelingsperger CP, Schurgers LJ. Vascular calcification: the price to pay for anticoagulation therapy with vitamin K-antagonists. Blood Rev 2012; 26(4): 155-66.
54. Neven E, De Schutter TM, De Broe ME, D'Haese PC. Cell biological and physicochemical aspects of arterial calcification. Kidney Int 2011; 79(11): 1166-77.
55. Farzaneh-Far A, Proudfoot D, Shanahan C, Weissberg PL. Vascular and valvar calcification: recent advances. Heart 2001; 85(1): 13-7.
56. Guerin AP, Adda H, London GM, Marchais SJ. Cardiovascular disease in renal failure. Minerva Urol Nefrol 2004; 56(3): 279-88.
57. McEniery CM, McDonnell BJ, So A, et al. Anglo-Cardiff Aortic calcification is associated with aortic stiffness and isolated systolic hypertension in healthy individuals. Hypertension 2009; 53(3): 524-31.
58. McClelland RL, Chung H, Detrano R, Post W, Kronmal RA. Distribution of coronary artery calcium by race, gender, and age: results from the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 2006; 113: 30-7.
59. Minasi MG, Riminucci M, De Angelis L, et al. The meso-angioblast: a multipotent, self-renewing cell that originates from the dorsal aorta and differentiates into most mesodermal tissues. Development 2002; 129: 2773-83.
60. Tintut Y, Alfonso Z, Saini T, Radcliff K, Watson K, Bostrom K, Demer LL. Multilineage potential of cells from the artery wall. Circulation 2003. 108, 2505-2510.
61. Shanahan CM, Weissberg PL, Metcalfe JC. Isolation of gene markers of differentiated and proliferating vascular smooth muscle cells. Circ Res 1993; 73: 193-204.
62. Mackenzie NC, Zhu D, Longley L, Patterson CS, Kommareddy S, MacRaeVE. MOVAS-1 cell line: a new in vitro model of vascular calcification. Int J Mol Med 2011; 27: 663-8.
63. Essalihi R, Ouellette V, Dao HH, McKee MD, Moreau P. Phenotypic modulation of vascular smooth muscle cells during medial arterial calcification: a role for endothelin? J Cardiovasc Pharmacol 2004; 44: S147-50.
64. Narisawa S, Harmey D, Yadav MC, O'Neill WC, Hoylaerts MF, Millán JL. Novel inhibitors of alkaline phosphatase suppress vascular smooth muscle cell calcification. J Bone Miner Res 2007; 22: 1700-10.
65. Zhu D, Mackenzie NCW, Millán JL, Farquharson C, MacRae VE. The appearance and modulation of osteocyte marker expression during calcification of vascular smooth muscle cells. PLoS ONE 2011; 6(5): e19595.
66. Steitz SA, Speer MY, Curinga G, et al. Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Circ Res 2001; 89: 1147-54.
67. Johnson K, Polewski M, van Etten D, Terkeltaub R. Chondrogenesis mediated by PPi depletion promotes spontaneous aortic calcification in NPP1/mice. Arterioscler. Thromb. Vasc. Biol 2005; 25: 686-91.
68. Sage AP, Lu J, Tintut Y, Demer LL. Hyperphosphatemiainduced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in vitro. Kidney Int 2011; 79: 414-22.
69. Zavaczki E, Jeney V, Agarwal A, et al. Hydrogen sulfide inhibits the calcification and osteoblastic differentiation of vascular smooth muscle cells. Kidney Int 2011; 80: 731-9.
70. Watson KE, Bostrom K, Ravindranath R, Lam T, Norton B, Demer LL. TGF-beta 1 and 25-hydroxycholesterol stimulate osteoblastlike vascular cells to calcify. J Clin Invest 1994; 93: 2106-13.
71. Balica M, Bostrom K, Shin V, Tillisch K, Demer LL. Calcifying subpopulation of bovine aortic smooth muscle cells is responsive to 17 beta-estradiol. Circulation 1997; 95: 1954-60.
72. Tintut Y, Parhami F, Boström K, Jackson SM, Demer LL. cAMP stimulates osteoblast like differentiation of calcifying vascular cells. Potential signaling pathway for vascular calcification. J Biol Chem 1998; 27: 7547-53.
73. Radcliff K, Tang TB, Lim J, et al. Insulin-like growth factor-I regulates proliferation and osteoblastic differentiation of calcifying vascular cells via extracellular signal-regulated protein kinase and phosphatidylinositol 3-kinase pathways. Circ Res 2005; 96: 398-400.
74. Ting TC, Miyazaki-Anzai S, Masuda M, et al. Increased lipogenesis and stearate accelerate vascular calcification in calcifying vascular cells. J Biol Chem 2011; 286: 23938-49.
75. Li R, Mittelstein D, Lee J, et al. A dynamic model of calcific nodule destabilization in response to monocyte-and oxidized lipid induced matrix metalloproteinases. Am J Physiol Cell Physiol 2012; 302: C658-65.
76. Caplan AI. All MSCs are pericytes? Cell Stem Cell 2008; 3(3): 229-30.
77. Andreeva ER, Pugach IM, Gordon D, Orekhov AN. Continuous subendothelial network formed by pericyte-like cells in human vascular bed. Tissue Cell 1998; 30: 127-35.
78. Doherty MJ, Canfield AE. Gene expression during vascular pericyte differentiation. Crit Rev Eukaryot Gene Expr 1999; 9: 1-17.
79. Farrington-Rock C, Crofts NJ, Doherty MJ, Ashton BA, Griffin-Jones C, Canfield AE. Chondrogenic and adipogenic potential of microvascular pericytes. Circulation 2004; 110: 2226-32.
80. Kirton JP, Crofts NJ, George SJ, Brennan K, Canfield AE. Wnt/beta-catenin signaling stimulates chondrogenic and inhibits adipogenic differentiation of pericytes: potential relevance to vascular disease? Circ Res 2007; 101: 581-9.
81. Cola C, Almeida M, Li D, Romeo F, Mehta JL. Regulatory role of endothelium in the expression of genes affecting arterial calcification. Biochem Biophys Res Commun 2004; 320: 424-7.
82. Doherty MJ, Ashton BA, Walsh S, Beresford JN, Grant ME, Canfield AE. Vascular pericytes express osteogenic potential in vitro and in vivo. J Bone Miner Res 1998; 13: 828-38.
83. Canfield AE, Doherty MJ, et al. Role of pericytes in vascular calcification: a review. Z. Kardiol 2000; 89: 20-27.
84. Otsuru S, Tamai K, Yamazaki T, Yoshikawa H, Kaneda Y. Circulating bone marrow-derived osteoblast progenitor cells are recruited to the bone-forming site by the CXCR4/stromal cell-derived factor-1 pathway. Stem Cells 2008; 26(1): 223-34.
85. Lu C, Wan Y, Cao J, et al. Wnt-mediated reciprocal regulation between cartilage and bone development during endochondral ossification. Bone 2013; 53(2): 566-74.
86. Giachelli CM. Vascular calcification mechanisms. J Am Soc Nephrol 2004; 15(12): 2959-64.
87. Rutsch F, Ruf N, Vaingankar S, et al. Mutations in ENPP1 are associated with "idiopathic" infantile arterial calcification. Nat Genet 2003; 34: 379-81.
88. Luo G DP, McKee MD, Pinero GJ, Loyer E, Behringer RR, Karsenty G. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997; 386(March 6): 78-81.
89. Ketteler M, Bongartz P, Westenfeld R, et al. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: A cross sectional study. Lancet 2003; 361(9360): 827-33.
90. Farzaneh-Far A, Proudfoot D, Weissberg PL, et al. Matrix gla protein is regulated by a mechanism functionally related to the calcium-sensing receptor. Biochem Biophys Res Commun 2000; 277: 736-40.
91. Zebboudj AF, Imura M, Bostrom K. Matrix GLA protein, a regulatory protein for bone morphogenetic protein-2. J Biol Chem 2002; 277: 4388-94.
92. Munroe PB, Olgunturk RO, Fryns JP, et al. Mutations in the gene encoding the human matrix Gla protein cause Keutel syndrome. Nat Genet 1999; 21: 142-4.
93. Schurgers LJ, Teunissen KJ, Knapen MH, et al. Novel conformation-specific antibodies against matrix {gamma}-carboxyglutamic acid (Gla) protein: undercarboxylated matrix gla protein as marker for vascular calcification. Arterioscler Thromb Vasc Biol 2005; 25: 1629-33.
94. Jono S, Ikari Y, Vermeer C, et al. Matrix Gla protein is associated with coronary artery calcification as assessed by electron-beam computed tomography. Thromb Haemost 2004; 91: 790-4.
95. Price PA, Faus SA, Williamson MK. Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves. Arte-rioscler Thromb Vasc Biol 1998; 18: 1400-7.
96. Schafer C, Heiss A, Schwarz A, et al. The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 2003; 112: 357-66.
97. Coen G, Ballanti P, Balducci A, et al. Renal osteodystrophy: alpha-Heremans Schmid glycoprotein/fetuin-A, matrix GLA protein serum levels, and bone histomorphometry. Am J Kidney Dis 2006; 48: 106-13.
98. Ketteler M, Westenfeld R, Schlieper G, et al. Pathogenesis of vascular calcification in dialysis patients. Clin Exp Nephrol 2005; 9: 265-70.
99. Moe SM, Reslerova M, Ketteler M, et al. Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD). Kidney Int 2005; 67: 2295-304.
100. Stenvinkel P, Wang K, Qureshi AR, et al. Low fetuin-A levels are associated with cardiovascular death: impact of variations in the gene encoding fetuin. Kidney Int 2005; 67: 2383-92.
101. Wang AY, Woo J, Lam CW, et al. Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients. Nephrol Dial Transplant 2005; 20: 1676-85.
102. Giachelli CM, Bae N, Almeida M, Denhardt DT, Alpers CE, Schwartz SM. Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J Clin Invest 1993; 92: 1686-96.
103. Levy RJ, Schoen FJ, Levy JT, Nelson AC, Howard SL, Oshry LJ. Biologic determinants of dystrophic calcification and osteocalcin deposition in glutaraldehyde-preserved porcine aortic valve leaflets implanted subcutaneously in rats. Am J Pathol 1983; 113: 143-55.
104. Bostrom K, Watson KE, Horn S, Wortham C, Herman IM, Demer LL. Bone morphogenic protein expression in human atherosclerotic lesions. J Clin Invest 1993; 91: 1800-9.
105. Tanimura A, McGregor DH, Anderson HC. Matrix vesicles in atherosclerotic calcification. Proc Soc Exp Biol Med 1983; 172: 173-7.
106. Mohler ER 3rd, Gannon F, Reynolds C, Zimmerman R, Keane MG, Kaplan FS. Bone formation and inflammation in cardiac valves. Circulation 2001; 103: 1522-8.
107. Jono S, McKee MD, Murry CE, et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 2000; 87: E10-7.
108. Parhami F, Basseri B, Hwang J, Tintut Y, Demer LL. High density lipoprotein regulates calcification of vascular cells. Circ Res 2002; 91: 570-6.
109. Tintut Y, Parhami F, Bostrom K, Jackson SM, Demer LL. cAMP stimulates osteoblast-like differentiation of calcifying vascular cells: Potential signaling pathway for vascular calcification. J Biol Chem 1998; 273: 7547-53.
110. Parhami F, Morrow AD, Balucan J, et al. Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler Thromb Vasc Biol 1997; 17: 680-7.
111. Fukui N, Zhu Y, Maloney WJ, et al. Stimulation of BMP-2 expression by pro-inflammatory cytokines IL-1 and TNF-alpha in normal and osteoarthritic chondrocytes. J Bone Joint Surg Am 2003; 85-A: 59-66.
112. Rifas L, Arackal S, Weitzmann MN. Inflammatory T cells rapidly induce differentiation of human bone marrow stromal cells into mature osteoblasts. J Cell Biochem 2003; 88: 650-9.
113. Ahrens M, Ankenbauer T, Schroder D, et al. Expression of human bone morphogenetic proteins-2 or-4 in murine mesenchymal progenitor C3H10T1/2 cells induces differentiation into distinct mesenchymal cell lineages. DNA Cell Biol 1993; 12: 871-80.
114. Zebboudj AF, Shin V, Bostrom K. Matrix GLA protein and BMP-2 regulate osteoinduction in calcifying vascular cells. J Cell Biochem 2003; 90: 756-65.
115. Sweatt A, Sane DC, Hutson SM, Wallin R. Matrix Gla protein (MGP) and bone morphogenetic protein-2 in aortic calcified lesions of aging rats. J Thromb Haemost 2003; 1(1): 178-85.
116. Mathew S, Davies M, Lund R, et al. Function and effect of bone morphogenetic protein-7 in kidney bone and the bone-vascular links in chronic kidney disease. Eur J Clin Invest 2006; 36: 43-50.
117. Speer MY, McKee MD, Guldberg RE, et al. Inactivation of the osteopontin gene enhances vascular calcification of matrix Gla protein-deficient mice: evidence for osteopontin as an inducible inhibitor of vascular calcification in vivo. J Exp Med 2002; 196: 1047-55.
118. Giachelli CM, Speer MY, Li X, et al. Regulation of vascular calcification: roles of phosphate and osteopontin. Circ Res 2005; 96: 717-22.
119. Price PA, Faus SA, Williamson MK. Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption. Arterioscler Thromb Vasc Biol 2001; 21: 817-24.
120. Price PA, June HH, Buckley JR, Williamson MK. Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D. Arterioscler Thromb Vasc Biol 2001; 21: 1610-6.
121. Price PA, Caputo JM, Williamson MK. Bone origin of the serum complex of calcium, phosphate, fetuin, and matrix Gla protein: Biochemical evidence for the cancellous bone-remodeling compartment. J Bone Miner Res 2002; 17: 1171-9.
122. Sattler AM, Schoppet M, Schaefer JR, et al. Novel aspects on RANK ligand and osteoprotegerin in osteoporosis and vascular disease. Calcif Tissue Int 2004; 74: 103-6.
123. Hofbauer LC, Schoppet M. Clinical implications of the osteoprote-gerin/RANKL/RANK system for bone and vascular diseases. JAMA 2004; 292: 490-5.
124. Bucay N, Sarosi I, Dunstan CR, et al. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 1998; 12: 1260-8.
125. Collin-Osdoby P. Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin. Circ Res 2004; 95: 1046-57. [107-109] [71-73].
126. Johnson RC, Leopold JA, Loscalzo J. Vascular calcification: pathobiological mechanisms and clinical implications. Circ Res 2006; 99(10): 1044-59.
127. Johnson K, Moffa A, Chen Y, Pritzker K, Goding J, Terkeltaub R. Matrix vesicle plasma cell membrane glycoprotein-1 regulates mineralization by murine osteoblastic MC3T3 cells. J Bone Miner Res 1999; 14: 883-92.
128. Parhami F, Jackson SM, Tintut Y, et al. Atherogenic diet and minimally oxidized low density lipoprotein inhibit osteogenic and promote adipogenic differentiation of marrow stromal cells. J Bone Miner Res 1999; 14: 2067-78.
129. Pohle K, Maffert R, Ropers D, et al. Progression of aortic valve calcification: Association with coronary atherosclerosis and cardiovascular risk factors Circulation 2001; 104: 1927-32.
130. O'Brien KD, Reichenbach DD, Marcovina SM, Kuusisto J, Alpers CE, Otto CM. Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of 'degenerative' valvular aortic stenosis. Arterioscler Thromb Vasc Biol 1996; 16: 523-32.
131. Parhami F, Tintut Y, Beamer WG, Gharavi N, Goodman W, Demer LL. Atherogenic high-fat diet reduces bone mineralization in mice. J Bone Miner Res 2001; 16: 182-8.
132. Tamashiro M, Iseki K, Sunagawa O, et al. Significant association between the progression of coronary artery calcification and dyslipidemia in patients on chronic hemodialysis. Am J Kidney Dis 2001; 38: 64-9.
133. Novaro GM, Tiong IY, Pearce GL, Lauer MS, Sprecher DL, Griffin BP. Effect of hydroxymethylglutaryl coenzyme a reductase inhibitors on the progression of calcific aortic stenosis. Circulation 2001; 104: 2205-09.
134. Goettsch C, Rauner M, Pacyna N, Hempel U, Bornstein SR, Hof-bauer LC. miR-125b regulates calcification of vascular smooth muscle cells. Am J Pathol 2011; 179: 1594-600.
135. Cui RR, Li SJ, Liu LJ, et al. MicroRNA-204 regulates vascular smooth muscle cell calcification in vitro and in vivo. Cardiovasc Res 2012; 96: 320-9.
136. Gui T, Zhou G, Sun Y, et al. MicroRNAs that target Ca2+ transporters are involved in vascular smooth muscle cell calcification. Lab Invest 2012; 92: 1250-9.
137. Schoen FJ, Tsao JW, Levy RJ. Calcification of bovine pericardium used in cardiac valve bioprostheses. Am J Pathol 1986; 123: 134-45.
138. Proudfoot D, Skepper JN, Hegyi L, Bennett MR, Shanahan CM, Weissberg PL. Apoptosis regulates human vascular calcification in vitro: Evidence for initiation of vascular calcification by apoptotic bodies. Circ Res 2000. 87: 1055-62.
139. Brimble KS, Ingram AJ, Eikelboom JW, Hart RG. Anticoagulants in patients with atrial fibrillation and end-stage renal disease. Postgrad Med 2012; 124(6): 17-25.
140. Douketis JD, Berger PB, Dunn AS, et al. American College of Chest Physicians. The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133(suppl 6): S299-339.
141. Furie B, Bouchard BA, Furie BC. Vitamin K-dependent biosynthesis of gamma-carboxyglutamic acid. Blood 1999; 93(6): 1798-808.
142. Howe AM, Webster WS. Warfarin exposure and calcification of the arterial system in the rat. Int J Exp Pathol 2000; 81(1): 51-6.
143. Ronden JE, Drittij-Reijnders MJ, Vermeer C, et al. Intestinal flora is not an intermediate in the phylloquinone-menaquinone-4 conversion in the rat. Biochim Biophys Acta 1998; 1379: 69-75.
144. Spronk HM, Soute BA, Schurgers LJ, et al. Tissue-specific utilization of menaquinone-4 results in the prevention of arterial calcification in warfarin-treated rats. J Vasc Res 2003; 40: 531-7.
145. Schurgers LJ, Spronk HM, Soute BA, et al. Regression of warfarin induced medial elastocalcinosis by high intake of vitamin K in rats. Blood 2007; 109: 2823-31.
146. Beazley KE, Banyard D, Lima F, et al. Transglutaminase Inhibitors Attenuate Vascular Calcification in a Preclinical Model. Arterio-scler Thromb Vasc Biol 2013; 33: 43-51.
147. Krüger T, Oelenberg S, Kaesler N, et al. Warfarin induces cardiovascular damage in mice. Arterioscler Thromb Vasc Biol 2013; 33(11): 2618-24.
148. Price PA, Faus SA, Williamson MK. Warfarin-induced artery calcification is accelerated by growth and vitamin D. Arterioscler Thromb Vasc Biol 2000; 20: 317-27.
149. Price PA, Chan WS, Jolson DM, et al. The elastic lamellae of devitalized arteries calcify when incubated in serum: evidence for a serum calcification factor. Arterioscler Thromb Vasc Biol 2006; 26: 1079-85.
150. Beazley KE, Eghtesad S, Nurminskaya MV. Quercetin attenuates warfarin-induced vascular calcification in vitro independently from MGP. J Biol Chem 2013; 288(4): 2632-40.
151. Nurminskaya M, Magee C, Faverman L, Linsenmayer TF. Chondrocyte derived transglutaminase promotes maturation of preosteoblasts in periosteal bone. Dev Biol 2003; 263: 139-52.
152. Nurminsky D, Shanmugasundaram S, Deasey S, et al. Transglutaminase 2 regulates early chondrogenesis and glycosaminoglycan synthesis. Mech Dev 2011; 128: 234-45.
153. Johnson KA, Terkeltaub RA. External GTP-bound transglutaminase 2 is a molecular switch for chondrocyte hypertrophic differentiation and calcification. J Biol Chem 2005; 280: 15004-12.
154. Chabot N, Moreau S, Mulani A, Moreau P, Keillor JW. Fluorescent probes of tissue transglutaminase reveal its association with arterial stiffening. Chem Biol 2010; 17: 1143-50.
155. Kaartinen MT, Murshed M, Karsenty G, McKee MD. Osteopontin upregulation and polymerization by transglutaminase 2 in calcified arteries of Matrix Gla protein-deficient mice. J Histochem Cyto-chem 2007; 55: 375-86.
156. Faverman L, Mikhaylova L, Malmquist J, Nurminskaya M. Extracellular transglutaminase 2 activates β-catenin signaling in calcifying vascular smooth muscle cells. FEBS Lett 2008; 582: 1552-7.
157. Johnson KA, Polewski M, Terkeltaub RA. Transglutaminase 2 is central to induction of the arterial calcification program by smooth muscle cells. Circ Res 2008; 102: 529-37.
158. Glass DA, Karsenty G. In vivo analysis of Wnt signaling in bone. Endocrinology 2007; 148: 2630-4.
159. Beazley KE, Deasey S, Lima F, Nurminskaya MV. Transglutaminase 2-Mediated Activation of β-Catenin Signaling Has a Critical Role in Warfarin-Induced Vascular Calcification. Arterio-scler Thromb Vasc Biol 2012; 32: 123-30.
160. Park CH, Chang JY, Hahm ER, Park S, Kim HK, Yang CH. Quer-cetin, a potent inhibitor against beta-catenin/Tcf signaling in SW480 colon cancer cells. Biochem Biophys Res Commun 2005; 328: 227-34.
161. Han W, Wang W, Mohammed KA, Su Y. Alpha-defensins increase lung fibroblast proliferation and collagen synthesis via the beta-catenin signaling pathway. FEBS J 2009; 276: 6603-14.
162. Shan BE, Wang MX, Li RQ. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and surviving expression through Wnt/beta-catenin signaling pathway. Cancer Invest 2009; 27: 604-12.
163. Beazley KE, Lima F, Borras T, Nurminskaya MV. Attenuation of chondrogenic transformation in vascular smooth muscle by dietary quercetin in the MGP-deficient mouse model. PLoS One 2013; 8(9): e76210.
164. El-Maadawy S, Kaartinen MT, Schinke T, et al. Cartilage formation and calcification in arteries of mice lacking matrix Gla protein. Connect Tissue Res 2003 44 Suppl 1: 272-8: 272-8.
165. Beazley KE, Lima F, Nurminsky D, Reckard S, Nurminskaya M. Two Sides of MGP-Null Arterial Disease: Chondrogenic Lesions Dependent on Transglutaminase 2 and Elastin Fragmentation Associated with Induction of Adipsin. J Biol Chem; 288(43): 31400-8.
166. Caira FC, Stock SR, Gleason TG, et al. Human degenerative valve disease is associated with up-regulation of low-density lipoprotein receptor-related protein 5 receptor-mediated bone formation. J Am Coll Cardiol 2006; 47: 1707-12.
167. Shao JS, Cheng SL, Pingsterhaus JM, Charlton-Kachigian N, Loewy AP, Towler DA. Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals. J Clin Invest 2005; 115: 1210-20.
168. Cheng SL, Shao JS, Halstead LR, Distelhorst K, Sierra O, Towler DA. Activation of vascular smooth muscle parathyroid hormone receptor inhibits Wnt/β-catenin signaling and aortic fibrosis in diabetic arteriosclerosis. Circ Res 2010; 107: 271-82.
169. Perez-Vizcaino F, Duarte J. Flavonols and cardiovascular disease. Mol Aspects Med 2010; 31(6): 478-94.